PMBP缩2-氨基苯并噻唑席夫碱及其稀土配合物的合成与表征

在非水溶剂中合成出1-苯基-3-甲基-4-苯甲酰基-吡唑啉酮-5(PMBP)缩2-氨基苯并噻唑席夫碱(HL)及其8种稀土元素配合物.由元素分析、络合滴定法和摩尔电导值推测出配合物的组成通式为RE(L)2·2H2O[RE=Eu,Tb,Sm,Dy,La,Nd,Pr,Gd],通过红外光谱、紫外光谱、热重谱和液相色谱-质谱联用技术对配体和配合物进行了结构表征.表征结果显示:配体在测试条件下以酮式和烯醇式结构共存,配位时酮式可能转化为烯醇式结构按去质子的方式以两分子吡唑啉酮环羟基上的两个O原子和两分子H2O上的两个O原子以及亚胺基和苯并噻唑环上的4个N原子与稀土中心离子成键,配合物的配位数均为8.     

CPPαFP缩糠胺席夫碱铜配合物的合成及其与DNA相互作用

合成出一种新型酰基吡唑啉酮席夫碱试剂(HL):1-对氯苯基-3-苯基-4-(α-呋喃甲酰基)-吡唑啉酮-5缩糠胺席夫碱及其铜配合物。由元素分析、络合滴定法、红外光谱、热重谱、质谱和核磁共振氢谱对配体和配合物的结构进行了表征并推测出配合物组成为CuL2,同时对该配合物与小牛胸腺DNA之间的相互作用进行了研究。结果表明:在测试条件下,配体以酮式和烯醇式共存。配位时酮式结构可能转化为烯醇式结构,按去质子的方式以羟基上的氧负离子和亚胺基上的氮原子双齿形式与铜中心离子成键;与小牛胸腺DNA作用实验结果显示:配合物主要以插入方式与CT-DNA相互作用,嵌入CT-DNA的碱基对中。     

Cd(Ⅱ)双苯吡唑基吡啶-草酸混配合物的合成、结构与性质

合成了Cd(Ⅱ)与类蝎型吡唑衍生物和草酸的混合配体的配合物[Cd2(HL)2(ox)]·1.5H2O(H2L=2,6-二(5-苯基-吡唑-3-基)吡啶,H2ox=草酸)。 通过元素分析、红外光谱、紫外光谱、X射线粉末衍射(PXRD)和X射线单晶结构分析确定了配合物的结构。 配合物晶体属于三斜晶系、P-1空间群,Cd(Ⅱ)是六配位,由一个ox2-基中的2个O原子和来自2个HL-中的4个N原子配位,构成变形八面体配位构型,而相邻Cd(Ⅱ)原子间均通过HL-上的N原子和草酸根分别连接形成2条互不相交的一维无限链状结构。 性质测试结果表明,该配合物具有良好的热稳定性和荧光特性,对环己烷氧化反应也具有一定的催化活性。     

两个由4-酰基吡唑啉酮衍生物构筑的Mn(Ⅱ)配合物的合成、晶体结构及性质(英文)

以4-酰基吡唑啉酮衍生物为配体合成了2个Mn(Ⅱ)配合物[Mn2L2(μ-CH3OH)2(CH3OH)2](1)和{[Mn L(μ-CH3OH)]·CH3OH·CHCl3}n(2)(H2L=N-(1-苯基-3-苄基-4-丙烯基-5-吡唑啉酮)-异烟酰肼),利用元素分析、红外光谱、紫外光谱、热重和X-射线单晶衍射分析进行了表征。结果表明反应体系的p H值影响配体的配位方式,所得配合物1为双核结构,而2为2D网状结构。热重分析表明,配合物1的稳定性高于配合物2的。     

2，5-二(2′-苯并咪唑)吡啶及其锌配合物的合成、结构与性能

本文利用微波法合成了2,5-二(2′-苯并咪唑)吡啶,采用水热合成技术得到了它的单晶(1)及其锌的配合物[Zn(C19H12N5)2(H2O)2].5H2O(2)。IR和X-射线单晶衍射实验测定和结构解析结果表明,化合物1由2,5-二(2′-苯并咪唑)吡啶和晶格水组成,化合物2中Zn2+离子与2,5-二(2′-苯并咪唑)吡啶的N原子配位,通过氢键作用形成1D链状结构,再通过配体间π-π作用形成三维结构。此外,TG和荧光测定分析表明化合物2具有良好的热稳定性和荧光性能。     

N,N',N″-三-(2-羟基丙基)-1,4,7-三氮杂环癸烷钴(Ⅱ)配合物的合成及其结构表征

合成了侧臂带有醇羟基的十元环大环三胺衍生物配体N,N',N″-三-(2-羟基丙基)-1,4,7-三氮杂环癸烷(L)及它的过渡金属配合物[CoL][ClO_4]_2,利用元素分析、红外光谱以及热重分析等技术手段对其结构进行了表征,并测定了配合物的晶体结构。解析结果表明,配合物属于Monoclinic晶系,P2(1)/n空间群,中心的Co(Ⅱ)原子为六配位,处于一个畸变的三棱柱配位环境。其中6个配位原子分别来自配体的3个N原子和3个O原子。平均的Co—N键长和Co—O键长分别为:0.2114(6)和0.2097(6)nm。高氯酸根中的3个氧原子分别与邻近的配合物阳离子中的3个O原子通过氢键O…H—O连接起来,形成了一个具有规则结构的超分子网络结构。     

配合物[Ni(IDB)2]2•(SO4)2•3CH3CH2OH•CH3OH•5H2O的合成、 晶体结构及其荧光光谱的研究

标题配合物是由三齿配体N,N-二(2-苯并咪唑甲基)亚胺(IDB)与NiSO4•6H2O在甲醇-乙醇溶液中反应得到的紫色晶体. X射线衍射测定了其单晶结构. 结构分析表明, 镍(II)分别与两个IDB配体中的苯并咪唑的四个氮和胺基的两个氮配位形成畸变的八面体构型. 研究了纳米金和小牛胸腺DNA对配合物荧光的影响, 探讨了配合物的荧光猝灭与恢复的可能机理.     

4-酰基-双(1,3-二苯基-5-吡唑啉酮)铽(Ⅲ)配合物的合成及荧光性质

合成了3种4-酰基-双(1,3-二苯基-5-吡唑啉酮),1,5-双(1,3-二苯基-5-吡唑啉酮-4-基)-1,5-戊二酮;1,6-双(1,3-二苯基-5-吡唑啉酮-4-基)-1,6-己二酮和1,10-双(1,3-二苯基-5-吡唑啉酮-4-基)-1,10-癸二酮,通过元素分析、红外光谱和核磁共振氢谱对产物组成进行了表征.合成了它们的Tb(Ⅲ)二元和三元[1,10-二氮杂菲(Phen) 或2,2-联吡啶(Dipy)]配合物,测定了配合物的荧光光谱,对其荧光性质进行了研究.结果表明,配合物发射Tb(Ⅲ)的特征荧光,4-酰基-双(1,3-二苯基-5-吡唑啉酮)配体的三重态能级与Tb(Ⅲ)的最低激发态(5D4)能级匹配较好;配合物荧光强度随4-酰基-双(1,3-二苯基-5-吡唑啉酮)配体2个吡唑环间碳链的增长而减弱;第2配体Phen 和Dipy具有荧光增强作用,且前者优于后者.     

六(3,3-二甲基-1-(1H-1,2,4-三唑)-2-丁酮)锌高氯酸盐配合物的合成及晶体结构

3，3-二甲基-1－（1H－1，2，4-三唑）－2-丁酮的锌配合物（C48H78Cl2N18O14Zn）已被合成。X-射线衍射结构分析表明，晶体属单斜晶系，空间群P21／n，晶体学数据：晶体体积结构偏离因子，标题配合物分子中6个三唑环上的4位N原子与Zn原子配位，形成八面体结构，锌原子处在结晶学的对称中心上。     

由4-氯-6-[2-(吡嗪-2-基亚甲基)肼基]嘧啶构筑的一维银配合物及其抗氧化和抑菌性能

由4-氯-6-[2-(吡嗪-2-基亚甲基)肼基]嘧啶(HL)和硝酸银合成了一维链状配位聚合物[Ag(C_(10)H_9N_6Cl)(NO_3)]_n(1)。在配合物1中,中心Ag离子与来自配体吡嗪环上的N5原子及另一配体上的N1、N4、N6原子进行配位,形成了锯齿形的一维链状结构。此外,锯齿形一维链通过N—H…O和N—H…N氢键相互作用及π-π堆积形成了三维的超分子结构。研究结果表明,与配体HL相比配合物1对超氧负离子和羟基自由基具有更强的自由基清除效能;配合物1对不同细菌的抗菌效果也优于配体HL。     

Structural diversity within analogous compounds: syntheses and studies of M(SCH2CH2NH2)Cl (M = Zn, Cd, Hg)

The novel complexes [Zn(L)Cl] (1), [Cd(L)Cl] (2), [Hg(L)Cl] (3), {[Hg(L)Cl].NaOH.2H2O} (3.NaOH.2H2O), and {[Hg3(HL)2Cl6].2H2O} (4) (L = -SCH2CH2NH2) were prepared and investigated by means of IR spectroscopy and single-crystal X-ray diffraction. The crystal structures of 1, 2, and 3.NaOH.2H2O show chelating N,S-coordination of the cysteaminate ligand, bridging S, and terminally coordinating Cl. Apart from these common features, the coordination geometries and modes of intermolecular association are different. 1 forms a cyclic tetramer with a Zn4S4 ring, and 3.NaOH.2H2O contains one-dimensional [Hg(L)Cl]n chains with S-bridged Hg atoms. Zn and Hg atoms in 1 and 3.NaOH.2H2O are tetracoordinate with a distorted tetrahedral M(ClNS2) geometry (M = Zn, Hg). Each Cd atom of 2 binds to three S atoms and vice versa, such that layers of distorted Cd3S3 hexagons are formed. 2 is the first example for a compound exhibiting a group 12-group 16 layer structure, which can be described as an analogue of a graphite layer. Additionally, each Cd atom binds to a chlorine atom and a nitrogen atom from a cysteaminate ligand resulting in pentacoordination with a distorted trigonal bipyramidal Cd(ClNS3) geometry. 4 contains two differently coordinate Hg atoms. One displays a distorted trans-octahedral Hg(Cl4S2) geometry, while the other is coordinated by four Cl atoms and one S atom and additionally forms a long Hg...Cl contact.     

An unsymmetrical tripodal ligand with NOS2-donor set: coordination chemistry with nickel(II) and zinc(II)

The synthesis of the novel tripodal ligand [N(CH2CH2CH2OH)(CH2CH2SH)2] H3-4 is reported. The aliphatic tetradentate ligand is equipped with an unsymmetrical NOS2 donor set. It reacts with Ni(OAc)2 x 4H2O or Zn(BF4)2 x xH2O to give the complexes [Ni(H-4)]2 5 and [Zn(H-4)]4 6, respectively. The molecular structures of 5 and 6 have been determined by X-ray diffraction. In both cases multinuclear, mu-thiolato-bridged complexes, wherein the ligand coordinates with only three (NS2) of the four donor groups, had formed. The dinuclear complex 5 adopts a butterfly geometry and contains nickel(II) ions in a square-planar NS3 coordination environment. Cyclic voltammetry experiments indicate that the nickel centers in 5 are electron-rich but not overly sensitive toward oxidation. Complex 6 is tetranuclear and the four thiolato-bridged metal centers form a ring. It shows a distorted tetrahedral coordination geometry for the zinc(II) ions in an NS3 coordination sphere. In both complexes the hydroxyl functionalized ligand arm of the tripodal ligand remains uncoordinated.     

Preparation, spectrochemical, and computational analysis of L-carnosine (2-[(3-aminopropanoyl)amino]-3-(1H-imidazol-5-yl)propanoic acid) and its ruthenium (II) coordination complexes in aqueous solution

This study reports the synthesis and characterization of novel ruthenium (II) complexes with the polydentate dipeptide, L-carnosine (2-[(3-aminopropanoyl)amino]-3-(1H-imidazol-5-yl)propanoic acid). Mixed-ligand complexes with the general composition [ML(p)(Cl)(q)(H?O)(r)]·xH?O (M = Ru(II); L = L-carnosine; p = 3 - q; r = 0-1; and x = 1-3) were prepared by refluxing aqueous solutions of the ligand with equimolar amounts of ruthenium chloride (black-alpha form) at 60 °C for 36 h. Physical properties of the complexes were characterized by elemental analysis, DSC/TGA, and cyclic voltammetry. The molecular structures of the complexes were elucidated using UV-Vis, ATR-IR, and heteronuclear NMR spectroscopy, then confirmed by density function theory (DFT) calculations at the B3LYP/LANL2DZ level. Two-dimensional NMR experiments (1H COSY, 13C gHMBC, and 1?N gHMBC) were also conducted for the assignment of chemical shifts and calculation of relative coordination-induced shifts (RCIS) by the complex formed. According to our results, the most probable coordination geometries of ruthenium in these compounds involve nitrogen (N1) from the imidazole ring and an oxygen atom from the carboxylic acid group of the ligand as donor atoms. Additional thermogravimetric and electrochemical data suggest that while the tetrahedral-monomer or octahedral-dimer are both possible structures of the formed complexes, the metal in either structure occurs in the 2? oxidation state. Resulting RCIS values indicate that the amide-carbonyl, and the amino-terminus of the dipeptide are not involved in chelation and these observations correlate well with theoretical shift predictions by DFT.     

新型二维异核配位聚合物{[NdBi(cydta)(NO3)2(H2O)4]•2.5H2O}n的 晶体结构与热分解

由Bi(Hcydta)•5H2O和Nd(NO3)•6H2O按1︰1的物质的量比, 在水溶液中合成了含Bi(III)-Nd(III)的异核配位聚合物{[(NO3)Nd(H2O)4(μ3-cydta)Bi(μ-ONO2)]•2.5H2O}n. 用元素分析、红外光谱、热重-差热和X射线单晶衍射等手段对标题配合物的组成和结构进行了表征. 该配合物属三斜晶系, 空间群 , 晶胞参数: a＝0.9235(3) nm, b＝1.0902(4) nm, c＝1.4253(5) nm, α＝71.840(4)°, β＝86.877(4)°, γ＝76.991(4)°, Z＝2, Mr＝936.65, V＝1.3284(8) nm3, Dc＝2.342 g• cm－3, μ＝8.646 mm－1, F(000)＝900, 最终偏离因子R1＝0.0406, wR2＝0.1124. 在该配合物中, 铋(III)与配体cydta4－的4O2N和1个硝酸根中1个O原子以及邻位分子的硝酸根形成8配位的畸变双帽三棱柱. 钕(III)与4个水分子的O, 1个硝酸根中2个O以及来自3个不同配体cydta4－的桥联羧基O结合, 形成9配位的三帽三棱柱构型. 羧酸根在Bi—Nd和硝酸根在Bi—Bi间的桥联作用, 使得整个配合物分子连接成无限二维框架结构. 热分析以及分解产物的红外光谱表明配合物热分解经历脱水、配体热分解、硝酸盐转变成氧化物等多步连续分解过程, 最后在625 ℃失重恒定.     

Influence of the metal size in the structure of the complexes derived from a pentadentate [N(3)O(2)] hydrazone

The influence of the metal size in the nuclearity of the complexes derived from the hydrazone ligand 2,6-bis(1-salicyloylhydrazonoethyl)pyridine [H(4)daps] has been investigated. We have synthesised a series of new complexes [M(H(x)daps)] x yH(2)O, (x = 2,3; y = 0-3) with M = Ag (1), Cd (2), Al (3), Sn (4) and Pb (6), using an electrochemical procedure. The crystal and molecular structures have been determined for the mononuclear complexes [Sn(H(2)daps)(H(2)O)(2)] x 4H(2)O (5) and [Pb(H(2)daps)(CN)][Et(4)N] (7). Complex is the first neutral Sn(II) complex derived from a pentadentate hydrazone Schiff base ligand. Complex shows the lead coordinated to the hydrazone donor set and a cyanide ligand, being the first reported complex with the lead atom coordinated to a monodentate cyanide group. Additionally, we have synthesised the lead complex using chemical conditions, in the presence of sodium cyanide which allowed us to isolate the neutral complex [Pb(H(2)daps)] (8). Evaporation of these mother liquors led the novel compound [Pb(Hdaphs)(CH(3)COO)] (9). Complex 9 shows the initial ligand hydrolysed in one of the imine bonds giving rise to a new tetradentate ligand [H(2)daphs] coordinated to the lead atom and a bidentate acetate group. Moreover, the solution behaviour of the complexes has been investigated by (1)H, (113)Cd, (117)Sn and (207)Pb NMR techniques. In particular multinuclear NMR has provided new useful data to correlate factors such as oxidation state, coordination number and nature of the kernel donor atoms due to the new coordination found in complexes 5 and 7. The comparative study of the structures of the complexes derived from this pentadentate [N(3)O(2)] hydrazone ligand let us to conclude that the metal size is a key factor to control the nuclearity of the complexes derived from the ligand [H(4)daps].     

由己二酸根桥联的新颖双U形四核铜配合物: [Cu4(phen)4(NO3)2(H2O)2(adip)4/4(Hadip)4/2](NO3)2•2H2O

邻菲罗啉、己二酸和硝酸铜在水溶液中反应得到一种新颖的四核铜配合物[Cu4(phen)4(NO3)2(H2O)2- (adip)4/4(Hadip)4/2](NO3)2•2H2O (其中H2adip＝己二酸), 并经元素分析, IR, UV, TG和X射线单晶衍射分析表征. 该配合物晶体属三斜晶系, 空间群, a＝1.0146(2) nm, b＝1.0261(2) nm, c＝1.8285(4) nm, α＝91.66(3)°, β＝92.19(3)°, γ＝112.76(3)°, V＝1.7520(6) nm3, Z＝1, Dc＝1.639 g/cm3, C66H66Cu4N12O28, Mr＝1729.47, F(000)＝886, μ＝1.294 mm－1, R1和wR2分别为0.0447和0.1141. 己二酸根通过4个羧基O将两个U形双核亚单元联接成具有一个对称中心的双U形四核结构, 其中每个U型亚单元包含晶体学上不对称的2个Cu(II)原子. 每个Cu(II)离子均处于畸变的四方锥配位环境, 除与己二酸氢根(Hadip)、己二酸根(adip)和邻菲罗啉(Phen)的N, O配位形成锥底平面外, 其中的1个Cu(II)与水配位, 而另一个Cu(II)则与硝酸根配位. 配合物晶体结构中存在着广泛的氢键和p×××p作用.     

X-ray structure characterization of palladium(II) ternary complexes of pyridinedicarboxylic and phthalic acid with phenanthroline and bipyridine

The crystal structures of the series of four ternary complexes, [Pd(phen)(2,6-PDCA)].4H(2)O (1) (phen=1,10-phenanthroline; 2,6-PDCA=2,6-pyridinedicarboxylic acid), [Pd(bpy)(2,3-PDCA)].3H(2)O (2) (bpy=2,2'-bipyridineand; 2,3-PDCA=2,3-pyridinedicarboxylic acid) and [Pd(phen)(PHT)].2.5H(2)O (3) (PHT=o-phthalic acid ) and [Pd(bpy)(PHT)].1.5H(2)O (4), are determined and the coordination modes of palladium(II) ternary complexes are characterized. All complexes take the mononuclear Pd(II) complexes, in which central Pd(II) atom of each complex has a similar distorted square-planar four coordination geometry. In all complexes, the aromatic heterocyclic compounds, phen and bpy, behave as a bidentate N, N' ligand. In the complex 1 and 2, 2,6-PDCA and 2,3-PDCA behave as a bidentate N, O ligand, and in complex 3 and 4, PHT behaves as a bidentate O, O' ligand.     

Structural studies and anticancer activity of a novel (N6O4) macrocyclic ligand and its Cu(II) complexes

A novel (N6O4) macrocyclic ligand (L) and its Cu(II) complexes have been prepared and characterized by elemental analysis, spectral, thermal (TG/DTG), magnetic, and conductivity measurements. Quantum chemical calculations have also been carried out at B3LYP/6-31+G(d,p) to study the structure of the ligand and one of its complexes. The results show a novel macrocyclic ligand with potential amide oxygen atom, amide and amine nitrogen atoms available for coordination. Distorted square pyramidal ([Cu(L)Cl]Cl·2.5H2O (1), [Cu(L)NO3]NO(3)·3.5H2O (2), and [Cu(L)Br]Br·3H2O (4) and octahedral ([Cu(L)(OAc)2]·5H2O (3)) geometries were proposed. The EPR data of 1, 2, and 4 indicate d1x2(-y)2 ground state of Cu(II) ion with a considerable exchange interaction. The measured cytotoxicity for L and its complexes (1, 2) against three tumor cell lines showed that coordination improves the antitumor activity of the ligand; IC50 for breast cancer cells are ≈8.5, 3, and 4 μg/mL for L and complexes (1) and (2), respectively.     

Structure and dynamics of methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-L-lyxo-hexopyranoside complexes with PtCl(2) and PdCl(2), by (1)H, (2)H, (13)C, (15)N and (195)Pt NMR spectroscopy in DMSO, CD(3)CN and H(2)O

Pd(ii) and Pt(ii) chloride complexes with LL = methyl cis-3,4-diamino-2,3,4,6-tetradeoxy-alpha-l-lyxo-hexopyranoside of the formulae [Pd(LL)Cl(2)] and [Pt(LL)Cl(2)], , were studied by (1)H, (2)H, (13)C, (15)N and (195)Pt NMR spectroscopy. These techniques were applied for characterization of the structure and ligand exchange dynamics, in case of diastereomeric species formed from in DMSO-d(6), DMSO-h(6) and H(2)O; their general formula was [Pt(LL)XY](+) (X = Cl, Y = DMSO-d(6), ; X = DMSO-d(6), Y = Cl, ; X = Cl, Y = DMSO-h(6), '; X = DMSO-h(6), Y = Cl, '; X = Cl, Y = H(2)O, ; X = H(2)O, Y = Cl, ). Their theoretical structures and NMR parameters, calculated at the level of DFT approach, were also presented and compared to the experimental data. The model complex [Pt(trans-diaminocyclohexane)Cl(2)], , was studied as well. To the best of our knowledge, this work is the first account dealing with the detailed analysis of structure and dynamics of ligand exchange processes in organic solvents and water, performed for a PtCl(2) complex containing a diaminosugar moiety. The kinetic behavior of the studied coordination compounds suggests that some of them may be potentially active in bioassays against cancer cells. Compound exhibits noticeable versatile ligand exchange possibilities in DMSO and H(2)O. Particularly, it undergoes solvolysis in DMSO-d(6), exchanging one chloride atom and yielding two diastereomers and ; the former, being the kinetically favored species, has the DMSO-d(6) ligand syn to the N(3) atom. The lyophilisate of the respective + mixture, earlier equilibrated in DMSO-d(6), after dissolving in H(2)O yields only the latter isomer, which is thermodynamically favored. The solvolysis of in H(2)O yields instantaneously two diastereomeric monoaquated species, and , amounting to 10% of each.